BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

156 related articles for article (PubMed ID: 16079982)

  • 1. Proton MR spectroscopy in three children with Tay-Sachs disease.
    Aydin K; Bakir B; Tatli B; Terzibasioglu E; Ozmen M
    Pediatr Radiol; 2005 Nov; 35(11):1081-5. PubMed ID: 16079982
    [TBL] [Abstract][Full Text] [Related]  

  • 2. MR findings in Tay-Sachs disease.
    Mugikura S; Takahashi S; Higano S; Kurihara N; Kon K; Sakamoto K
    J Comput Assist Tomogr; 1996; 20(4):551-5. PubMed ID: 8708054
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Serial MR imaging and 1H-MR spectroscopy in monozygotic twins with Tay-Sachs disease.
    Imamura A; Miyajima H; Ito R; Orii KO
    Neuropediatrics; 2008 Oct; 39(5):259-63. PubMed ID: 19294598
    [TBL] [Abstract][Full Text] [Related]  

  • 4. 31Phosphorus magnetic resonance spectroscopy in late-onset Tay-Sachs disease.
    Felderhoff-Mueser U; Sperner J; Konstanzcak P; Navon R; Weschke B
    J Child Neurol; 2001 May; 16(5):377-80. PubMed ID: 11392526
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Is magnetic resonance spectroscopy capable of detecting metabolic abnormalities in neurofibromatosis type 1 that are not revealed in brain parenchyma of normal appearance?
    Rodrigues AC; Ferraz-Filho JR; Torres US; da Rocha AJ; Muniz MP; Souza AS; Goloni-Bertollo EM; Pavarino ÉC
    Pediatr Neurol; 2015 Mar; 52(3):314-9. PubMed ID: 25585912
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Tay-Sachs disease: progression of changes on neuroimaging in four cases.
    Fukumizu M; Yoshikawa H; Takashima S; Sakuragawa N; Kurokawa T
    Neuroradiology; 1992; 34(6):483-6. PubMed ID: 1436455
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Unilaterally and rapidly progressing white matter lesion and elevated cytokines in a patient with Tay-Sachs disease.
    Hayase T; Shimizu J; Goto T; Nozaki Y; Mori M; Takahashi N; Namba E; Yamagata T; Momoi MY
    Brain Dev; 2010 Mar; 32(3):244-7. PubMed ID: 19278800
    [TBL] [Abstract][Full Text] [Related]  

  • 8. A case of infantile Tay-Sachs disease with late onset spasms.
    Yamamoto N; Kuki I; Nagase S; Inoue T; Nukui M; Okazaki S; Furuichi Y; Adachi K; Nanba E; Sakai N; Kawawaki H
    Brain Dev; 2021 May; 43(5):661-665. PubMed ID: 33483101
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Evaluation of early cerebral metabolic, perfusion and microstructural changes in HCV-positive patients: a pilot study.
    Bladowska J; Zimny A; Knysz B; Małyszczak K; Kołtowska A; Szewczyk P; Gąsiorowski J; Furdal M; Sąsiadek MJ
    J Hepatol; 2013 Oct; 59(4):651-7. PubMed ID: 23680314
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Presentation of central precocious puberty in two patients with Tay-Sachs disease.
    Acar S; Arslan N; Paketçi A; Okur TD; Demir K; Böber E; Abacı A
    Hormones (Athens); 2018 Sep; 17(3):415-418. PubMed ID: 29943104
    [TBL] [Abstract][Full Text] [Related]  

  • 11. 'Cherry red spot' in a patient with Tay-Sachs disease: case report.
    Aragão RE; Ramos RM; Pereira FB; Bezerra AF; Fernandes DN
    Arq Bras Oftalmol; 2009; 72(4):537-9. PubMed ID: 19820796
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Immunohistochemical demonstration of GM2-ganglioside in the central nervous system of a 19-week-old fetus of Tay-Sachs disease.
    Taniike M; Inui K; Hirabayashi Y; Tsukamoto H; Nishimoto J; Midorikawa M; Okada S; Yabuuchi H
    J Inherit Metab Dis; 1989; 12 Suppl 2():372-4. PubMed ID: 2512447
    [No Abstract]   [Full Text] [Related]  

  • 13. Serial changes of T1-, T2-weighted MR imaging and MR spectroscopy in Tay-Sachs disease with late onset spasms.
    Mugikura S; Mori N; Takahashi S
    Brain Dev; 2021 Oct; 43(9):975-976. PubMed ID: 34275686
    [No Abstract]   [Full Text] [Related]  

  • 14. Tay-Sachs disease with conspicuous cranial computerized tomographic appearances.
    Watanabe K; Mukawa A; Muto K; Nishikawa J; Takahashi S
    Acta Pathol Jpn; 1985 Nov; 35(6):1521-32. PubMed ID: 2936060
    [TBL] [Abstract][Full Text] [Related]  

  • 15. HIV-related metabolic abnormalities in the brain: depiction with proton MR spectroscopy with short echo times.
    Laubenberger J; Häussinger D; Bayer S; Thielemann S; Schneider B; Mundinger A; Hennig J; Langer M
    Radiology; 1996 Jun; 199(3):805-10. PubMed ID: 8638009
    [TBL] [Abstract][Full Text] [Related]  

  • 16. MRI volumetry and proton MR spectroscopy of the brain in Lafora disease.
    Villanueva V; Alvarez-Linera J; Gómez-Garre P; Gutiérrez J; Serratosa JM
    Epilepsia; 2006 Apr; 47(4):788-92. PubMed ID: 16650146
    [TBL] [Abstract][Full Text] [Related]  

  • 17. White matter proton MR spectroscopy in children with isolated developmental delay: does it mean delayed myelination?
    Fayed N; Morales H; Modrego PJ; Muñoz-Mingarro J
    Acad Radiol; 2006 Feb; 13(2):229-35. PubMed ID: 16428059
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Sandhoff's and Tay-Sachs disease--based on our own cases].
    Kokot W; Raczyńska K; Krajka-Lauer J; Iwaszkiewicz-Bilikiewicz B; Wierzba J
    Klin Oczna; 2004; 106(3 Suppl):534-6. PubMed ID: 15636260
    [TBL] [Abstract][Full Text] [Related]  

  • 19. White matter and cerebral metabolite changes in children undergoing treatment for acute lymphoblastic leukemia: longitudinal study with MR imaging and 1H MR spectroscopy.
    Chu WC; Chik KW; Chan YL; Yeung DK; Roebuck DJ; Howard RG; Li CK; Metreweli C
    Radiology; 2003 Dec; 229(3):659-69. PubMed ID: 14576448
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Cerebral metabolism in experimental hydrocephalus: an in vivo 1H and 31P magnetic resonance spectroscopy study.
    Braun KP; van Eijsden P; Vandertop WP; de Graaf RA; Gooskens RH; Tulleken KA; Nicolay K
    J Neurosurg; 1999 Oct; 91(4):660-8. PubMed ID: 10507389
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.